Alzheimer’s disease

Investigational new drug for Alzheimer’s scheduled for first study in humans

Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer’s disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.

Alzheimer’s study establishes way to measure resilience

Vanderbilt researchers have established a new measure of resilience to cognitive impairment in people with asymptomatic Alzheimer’s disease.

Elderly woman holding hands with young caretaker

Vanderbilt study shows people with Alzheimer’s have lower ability to perceive pain

People with Alzheimer’s disease don’t perceive pain as readily as healthy older adults, and this may lead to delays and underreporting of pain. This alteration in pain detection may be one reason that people with Alzheimer’s disease and pain tend to be undermedicated and suffer unnecessarily, a trans-institutional group of Vanderbilt researchers reported recently in BMC Medicine.

Alzheimer’s risk gene in younger adults

A genetic risk factor for Alzheimer’s disease in later life appears to benefit younger adults as they age.

Investigators explore African ancestry, Alzheimer’s risk

Higher genomic levels of African ancestry are associated with an increased risk for Alzheimer’s disease, a consortium of investigators reported recently in Alzheimer’s & Dementia.

The Vanderbilt Child and Family Center sponsored a

Experience simulated life with dementia through Virtual Dementia Tour April 20

Are you caring for a loved one with Alzheimer’s disease or dementia? Have you ever wondered what life is like for him or her? If you’d like to learn more, sign up for the Vanderbilt Child & Family Center’s Virtual Dementia Tour on April 20.

1 3 4 5 6 7